Dr. Agarwal's Eye Hospital Shows Strong Financial Growth Amid Rising Interest Expenses and Pledged Shares

Jun 03 2025 08:30 AM IST
share
Share Via
Dr. Agarwal's Eye Hospital has experienced an evaluation adjustment due to significant changes in its financial metrics. The company reported a strong quarterly performance with notable growth in net sales and operating profit. However, it faces challenges from rising interest expenses and a high percentage of pledged promoter shares.
Dr. Agarwal's Eye Hospital has recently undergone an evaluation adjustment, reflecting notable changes in its financial metrics and technical indicators. The company reported a positive financial performance for the quarter ending March 2025, with net sales reaching Rs 99.83 crore, marking a growth of 23.67%. Additionally, the PBDIT reached its highest level at Rs 31.59 crore, and the operating profit to net sales ratio stood at 31.64%, indicating strong operational efficiency.

On the technical side, the stock's trend has shifted from a mildly bearish stance to a sideways movement, suggesting a period of stabilization without clear momentum. The MACD indicators show a mildly bullish trend on a weekly basis, while the monthly outlook remains mildly bearish.

Despite the positive financial results, the company faces challenges, including a significant increase in interest expenses, which grew by 51.09% over the past nine months. Furthermore, a notable portion of promoter shares, 55.45%, are pledged, which could exert additional pressure in volatile market conditions.

Overall, the evaluation adjustment reflects a complex interplay of strong financial performance and technical trends, positioning Dr. Agarwal's Eye Hospital in a unique market context.

Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News